|
|
Fibrogen Inc (NASDAQ: FGEN) |
|
|
|
FGEN's Net Income Growth by Quarter and Year
Fibrogen Inc 's Net Income results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
|
FGEN Net Income (in millions $) |
FY 2025 |
FY 2024 |
FY 2023 |
FY 2022 |
4th Quarter |
December |
-
|
17.98
|
-56.23
|
-66.18
|
3rd Quarter |
September |
-
|
-17.08
|
-63.62
|
-91.65
|
2nd Quarter |
June |
-
|
-15.54
|
-87.68
|
-72.62
|
1st Quarter |
March |
4.64
|
-32.93
|
-76.71
|
-63.21
|
FY |
|
4.64
|
-47.57
|
-284.24
|
-293.66
|
FGEN Net Income first quarter 2025 Y/Y Growth Comment |
Fibrogen Inc in the first quarter 2025 achieved Net Income of $ 4.64 millions compare to net loss recorded in same quarter a year ago.
Looking into first quarter 2025 results within Major Pharmaceutical Preparations industry 29 other companies have achieved higher Net Income growth. While Fibrogen Inc ' s Net Income no change of % ranks overall at the positon no. 1390 in the first quarter 2025.
|
FGEN Net Income ( Y/Y Growth %) |
2025
|
2024 |
2023 |
2022 |
4th Quarter |
December |
- |
- |
- |
- |
3rd Quarter |
September |
- |
- |
- |
- |
2nd Quarter |
June |
- |
- |
- |
- |
1st Quarter |
March |
- |
- |
- |
- |
FY |
|
- |
- |
- |
- |
FGEN Net Income (Quarter on Quarter Growth %) |
2025
|
2024 |
2023 |
2022 |
4th Quarter |
December |
- |
- |
- |
- |
3rd Quarter |
September |
- |
- |
- |
- |
2nd Quarter |
June |
- |
- |
- |
- |
1st Quarter |
March |
-74.2 % |
- |
- |
- |
FY (Year on Year) |
|
- |
- |
- |
- |
Net Income Y/Y Growth Statistics |
High |
Average |
Low |
-74.2 % |
-74.2 % |
-74.2 % |
(Mar 31 2025) |
|
|
|
Net Income Y/Y Growth Statistics |
High |
Average |
Low |
-74.2 % |
-74.2 % |
-74.2 % |
(Mar 31 2025) |
|
|
|
Net Income by Quarter for the Fiscal Years 2022, 2023, 2024, 2025 |
Fibrogen Inc 's Q/Q Net Income Growth
Net Income Q/Q Growth Statistics |
High |
Average |
Low |
-74.2 % |
-74.2 % |
-74.2 % |
(Mar 31 2025) |
|
|
FGEN's I. Quarter Q/Q Net Income Comment |
In the I. Quarter 2025 Fibrogen Inc realized fall in Net Income from the fourth quarter by -74.2% to $ 4.64 millions, from $ 17.98 millions achived a quarter before.
Within Major Pharmaceutical Preparations industry 29 other companies have achieved higher Net Income quarter on quarter growth. While Fibrogen Inc 's Net Income growth quarter on quarter, overall rank is 1390. |
|
|
Net Income Q/Q Growth Statistics |
High |
Average |
Low |
-74.2 % |
-74.2 % |
-74.2 % |
(Mar 31 2025) |
|
|
FGEN's I. Quarter Q/Q Net Income Comment |
In the I. Quarter 2025 Fibrogen Inc disclosed fall in Net Income from the previous quarter by -74.2% to $ 4.64 millions, from $ 17.98 millions declared in the previous reporting period.
Within Major Pharmaceutical Preparations industry 29 other companies have achieved higher Net Income quarter on quarter growth. While Fibrogen Inc 's Net Income growth quarter on quarter, overall rank is 1390. |
|
Fibrogen Inc 's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending (Mar 31 2025) |
12 Months Ending (Dec 31 2024) |
12 Months Ending (Sep 30 2024) |
12 Months Ending (Jun 30 2024) |
12 Months Ending (Mar 31 2024) |
Cumulative Net Income 12 Months Ending |
$ -10.01 |
$ -47.58 |
$ -121.79 |
$ -168.32 |
$ -240.46 |
Y / Y Net Income Growth (TTM) |
- |
- |
- |
- |
- |
Year on Year Net Income Growth Overall
Ranking |
# |
# |
# |
# |
# |
Seqeuential Net Income Change (TTM) |
- |
- |
- |
- |
- |
Seq. Net Income Growth (TTM) Overall
Ranking |
# |
# |
# |
# |
# |
Cumulative Net Income growth Comment |
Fibrogen Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. . |
|
|
Net Income TTM Y/Y Growth Statistics |
High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
Net Income TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# |
Sector |
# |
S&P 500 |
# |
|
Cumulative Net Income growth
Comment |
Fibrogen Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. . |
Net Income TTM Y/Y Growth Statistics |
High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
Net Income TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# |
Sector |
# |
S&P 500 |
# |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com